DR
Therapeutic Areas
Suven Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Masupiridine (SUVN‑502) | Alzheimer's disease – cognition and neuropsychiatric symptoms | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Masupiridine (SUVN‑502) | Alzheimer's disease – cognition and neuropsychiatric symptoms | Preclinical |